Drug Discovery World

MAY 6, 2024

A more established Amsterdam-based enterprise is gene therapy company uniQure, developer of etranacogene dezaparvovec, the first gene therapy for haemophilia B, which was approved for use in the US in November 2022 and in the EU in February 2023. billion ($7.9

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

OCTOBER 6, 2022

until 2030. Michael Altorfer, CEO of the Swiss Biotech Association 6 , outlines why the country is faring well in this sector: “Given the small size of their domestic market, Swiss-based biotech and pharma companies have always focused on the global market and invested heavily in international collaborations and R&D networks.

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Pharma Companies Marketing 130

Drug Discovery World

FEBRUARY 10, 2023

This is reflected in the government’s aim of becoming a leader in the ATMP space by 2030. We have 3,000 companies in the life sciences sector. A good part of half of those are within pharma. The weakness connected to that is we have so few large pharmaceuticals. It’s also a seal of quality. Its value cannot be overstated.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Discovery World

AUGUST 8, 2023

In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. To many, the country is referred to as the ‘pharmacy of the world’. million) at the city’s life sciences hub 14.

Research 130

Research Pharmacy Pharmaceuticals Government 130